NACDS, HDA praise FDA move to preserve medication access as supply chain pursues DSCSA compliance
NACDS and HDA applaud Congressional engagement to prevent disruptions of patients’ access to prescription drugs through no fault of dispensers.
NACDS and HDA applaud Congressional engagement to prevent disruptions of patients’ access to prescription drugs through no fault of dispensers.
The discussions with staff centered around PBM reform.
Kellanova’s portfolio complements the existing Mars portfolio.
Prospective health benefits from GLP-1 drugs beyond weight loss and lower blood glucose continue to emerge.